Details for Patent: RE48183
✉ Email this page to a colleague
Which drugs does patent RE48183 protect, and when does it expire?
Patent RE48183 protects OMLONTI and is included in one NDA.
This patent has forty-three patent family members in twenty-six countries.
Drugs Protected by US Patent RE48183
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Visiox Pharma | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION IN PATIENTS | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE48183
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015205188 | ⤷ Sign Up | |||
| Brazil | 112016015763 | ⤷ Sign Up | |||
| Canada | 2936026 | ⤷ Sign Up | |||
| Chile | 2016001756 | ⤷ Sign Up | |||
| China | 105899209 | ⤷ Sign Up | |||
| China | 108743587 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
